Literature DB >> 33220881

The Role of Cardiovascular MRI in Cardio-Oncology.

Wendy Bottinor1, Cory R Trankle2, W Gregory Hundley2.   

Abstract

"Cardiac imaging is an essential tool in the field of cardio-oncology. Cardiovascular magnetic resonance (CMR) stands out for its accuracy, reproducibility, and ability to provide tissue characterization. These attributes are particularly helpful in screening and diagnosing cardiotoxicity, infiltrative disease, and inflammatory cardiac disease. The ability of CMR to detect subtle changes in cardiac function and tissue composition has made it a useful tool for understanding the pathophysiology of cardiotoxicity. Because of these unique features, CMR is gaining prominence in both the clinical and research aspects of cardio-oncology."
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardio-oncology; Cardiotoxicity; Cardiovascular MRI; Tissue characterization

Mesh:

Year:  2020        PMID: 33220881      PMCID: PMC8513991          DOI: 10.1016/j.hfc.2020.08.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  58 in total

1.  A population-based study of cardiovascular disease mortality risk in US cancer patients.

Authors:  Kathleen M Sturgeon; Lei Deng; Shirley M Bluethmann; Shouhao Zhou; Daniel M Trifiletti; Changchuan Jiang; Scott P Kelly; Nicholas G Zaorsky
Journal:  Eur Heart J       Date:  2019-12-21       Impact factor: 29.983

Review 2.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

3.  Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

Authors:  Joe-Elie Salem; Ali Manouchehri; Melissa Moey; Bénédicte Lebrun-Vignes; Lisa Bastarache; Antoine Pariente; Aurélien Gobert; Jean-Philippe Spano; Justin M Balko; Marc P Bonaca; Dan M Roden; Douglas B Johnson; Javid J Moslehi
Journal:  Lancet Oncol       Date:  2018-11-12       Impact factor: 41.316

4.  CMR-based differentiation of AL and ATTR cardiac amyloidosis.

Authors:  Jason N Dungu; Oswaldo Valencia; Jennifer H Pinney; Simon D J Gibbs; Dorota Rowczenio; Janet A Gilbertson; Helen J Lachmann; Ashutosh Wechalekar; Julian D Gillmore; Carol J Whelan; Philip N Hawkins; Lisa J Anderson
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

5.  Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Authors:  Marion Escudier; Jennifer Cautela; Nausicaa Malissen; Yann Ancedy; Morgane Orabona; Johan Pinto; Sandrine Monestier; Jean-Jacques Grob; Ugo Scemama; Alexis Jacquier; Nathalie Lalevee; Jeremie Barraud; Michael Peyrol; Marc Laine; Laurent Bonello; Franck Paganelli; Ariel Cohen; Fabrice Barlesi; Stephane Ederhy; Franck Thuny
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

6.  Cardiac dysfunction in the trastuzumab clinical trials experience.

Authors:  Andrew Seidman; Clifford Hudis; Mary Kathryn Pierri; Steven Shak; Virginia Paton; Mark Ashby; Maureen Murphy; Stanford J Stewart; Deborah Keefe
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.

Authors:  Jin Joo Park; Jun-Bean Park; Jae-Hyeong Park; Goo-Yeong Cho
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

8.  Dimensional accuracy of magnetic resonance in studies of the heart.

Authors:  D B Longmore; R H Klipstein; S R Underwood; D N Firmin; G N Hounsfield; M Watanabe; C Bland; K Fox; P A Poole-Wilson; R S Rees
Journal:  Lancet       Date:  1985-06-15       Impact factor: 79.321

Review 9.  Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2016-09       Impact factor: 10.047

10.  Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.

Authors:  Todd M Gibson; Zhenghong Li; Daniel M Green; Gregory T Armstrong; Daniel A Mulrooney; DeoKumar Srivastava; Nickhill Bhakta; Kirsten K Ness; Melissa M Hudson; Leslie L Robison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-22       Impact factor: 4.254

View more
  3 in total

Review 1.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

Review 2.  Cardiac MRI assessment of anthracycline-induced cardiotoxicity.

Authors:  Leila Mabudian; Jennifer H Jordan; Wendy Bottinor; W Gregory Hundley
Journal:  Front Cardiovasc Med       Date:  2022-09-27

Review 3.  Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care.

Authors:  Hugo R Martinez; Gary S Beasley; Jason F Goldberg; Mohammed Absi; Kaitlin A Ryan; Karine Guerrier; Vijaya M Joshi; Jason N Johnson; Cara E Morin; Caitlin Hurley; Ronald Ray Morrison; Parul Rai; Jane S Hankins; Michael W Bishop; Brandon M Triplett; Matthew J Ehrhardt; Ching-Hon Pui; Hiroto Inaba; Jeffrey A Towbin
Journal:  Children (Basel)       Date:  2021-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.